KEY POINTS
• Mi2β exerts a major part of its silencing effect on embryonic and fetal globin genes by positively regulating the BCL11A and KLF1 genes.
• Partial depletion of Mi2β induces increased γ -globin gene expression in primary human erythroid cells without impairing differentiation.
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INTRODUCTION
Hemoglobinopathies such as sickle cell anemia and β -thalassemia result from among the most common single gene defects worldwide. A promising approach for the treatment of these conditions is through the induction of increased fetal hemoglobin (HbF) expression.
Hydroxyurea, which is currently part of the standard treatment for sickle cell anemia, causes increased expression of HbF. However, the level of HbF induced in patients is variable and
Hydroxyurea is not effective in the treatment of β -thalassemia. Development of effective and potentially less toxic targeted strategies to induce HbF production, will require full understanding of the molecular basis of developmental repression of the fetal γ -globin gene. The γ -globin gene is located on chromosome 11 within the β -globin gene locus, which consists of a group of five β -type globin genes positioned in the order in which they are expressed during development and preceded by a locus control region (5'-LCR-ε- [1] [2] [3] . During the embryonic stage of development, the ε -globin gene is expressed in the yolk sac, followed by expression of the γ -globin gene in the fetal liver during most of gestation. At birth, γ -globin expression declines as the expression of adult β -globin in bone marrow derived erythroid cells predominates 4, 5 . There are numerous trans-acting factors and associated complexes involved in γ -globin gene silencing. These include BCL11A, KLF1/EKLF, MBD2/NuRD, TR2/TR4, and GATA-1/FOG-1/NuRD 1, 3, 6 . Among these, KLF1 (EKLF), a member of the Krüppel family of transcription factors, is critical in the expression of many erythroid-specific genes [7] [8] [9] .
KLF1/EKLF binds directly to, and positively regulates the β -globin gene in adult erythroid cells.
It also negatively regulates the γ -globin gene indirectly through its role in mediating competition between the γ -and β -globin promoters for the LCR, and by binding to and positively regulating expression of BCL11A, an important γ -globin gene silencing factor 10, 11 . Originally identified in
For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From a GWAS study 12 , BCL11A is a zinc finger transcription factor that acts as a dominant negative regulator of the embryonic to adult hemoglobin switch during murine development 13 . It binds to the locus control region as well as to an intergenic region located between the γ -globin and δ -globin genes 14 . Knockout of BCL11A in a humanized sickle cell transgenic mouse model greatly ameliorates the sickle cell disease phenotype 15 .
Epigenetic mechanisms, including DNA methylation and histone modifications, also play an important role in developmental globin gene silencing 6, [16] [17] [18] [19] [20] , and inhibitors of DNA methylation induce increased HbF levels in baboons and in humans [21] [22] [23] . The MBD2/NuRD complex, which selectively binds to methylated CpG-rich DNA, has been shown to play an important role in the silencing of the human embryonic ε -and fetal γ -globin genes [24] [25] [26] . NuRD co-repressor complexes include at least one copy of each of the proteins Mi2α and -β, HDAC-1 and -2, MTA-1 and -2, RbAp46/48, and p66α and p66β 27, 28 . MBD2/NuRD does not appear to interact directly with promoters of human β -type globin genes, suggesting that its silencing effects occur through an indirect pathway 24 . The MBD3/NuRD complex, which is distinct from MBD2/NuRD
29
, directly interacts with and regulates genes within the β -globin locus through its association with the transcription factors GATA-1 and Friend of GATA-1 (FOG-1) 30, 31 . In β YAC transgenic mice, the GATA-1/FOG-1/NuRD complex negatively regulates the γ -globin gene by binding to its distal promoter 32 . This complex is associated with positive regulation of the adult β -globin gene 33 , suggesting that GATA-1/FOG-1/NuRD can act as either an activator or repressor complex.
Mi2β (CHD4), the largest protein of the NuRD complex, is a chromatin organization modifier (Chd), and a member of the SNF2 family of helicases 34 . It confers the chromatin remodeling function of the NuRD complex. Mi2β is highly expressed in multiple tissues Blots were performed as previously described 25 .
CD34+ hematopoietic progenitor cell isolation. CD34+ cells were isolated from 10 mL de- For personal use only. on October 22, 2017. by guest www.bloodjournal.org From Chromatin Immunoprecipitation (ChIP) assays. 10 7 CID cells or CD34+ hematopoietic progenitor cells, the latter collected at day 2 of erythroid differentiation, were crosslinked by incubation with 2.0 mM ethylene glycol-bis(succinimidyl succinate) (EGS) at room temperature for 30 minutes followed by 1% formaldehyde for 10 minutes. ChIP assays were then performed using the EZ-Magna ChIP kit (Millipore, Billerica, MA, USA) per the vendor's protocol and enrichment of immunoprecipitated sequences was assayed by qPCR using primers described in Supplemental Table 1 . Mi2β knockdown the murine ε y gene is de-repressed to a much greater extent than β h1 (>100-fold versus ~3-fold), an observation similar to the relative effect on the human fetal and embryonic β -type globin genes, in which the γ -globin gene is up-regulated much more than the ε -globin gene (>3000-fold versus ~350-fold). These data are also consistent with the finding that the ε y gene is activated later in murine erythroid development than β h1 38 and thus is more analogous to the human γ -globin gene than is β h1.
RESULTS

Mi2β is an important developmental regulator of human
Because both Mi2β and its isoform, Mi2α (CHD3) have been shown to be incorporated into NuRD complexes [39] [40] [41] , we examined the role of Mi2α in γ -globin gene silencing. The level of Mi2α RNA was found to be ~10-15-fold lower than Mi2β RNA by qPCR (data not shown).
Knockdown of Mi2α, to the same degree as for Mi2β knockdown, had only a minor (~1.5-fold) effect on γ -globin gene expression in CID cells (Supplemental Figures S1A and S1B), suggesting that the great majority of γ -globin gene silencing requires only the Mi2β (CHD4) isoform.
Based on the observation that Mi2β knockdown had a larger effect on γ -globin expression than did MBD2 knockdown, we explored the possibility that loss of Mi2β, the largest component of the MBD2/NuRD complex, could lead to destabilization of the complex and reduce the levels of other components, thereby creating a larger effect than loss of an individual component. Western blot and MBD2 co-precipitation assays in cells in which Mi2β was knocked down by ~80-90%, showed that other components of the MBD2/NuRD complex are present in normal abundance and able to interact despite depletion of Mi2β (Supplemental Figure   S2 ).
Mi2β silences the γ -globin gene in human primary erythroid cells
To determine the role of Mi2β on γ -globin gene silencing in the context of primary adult human erythroid cells, we stably knocked down Mi2β in CD34+ human hematopoietic progenitor derived erythroid cells via lentivirus-mediated shRNA infection. Two different Mi2β shRNA constructs were tested. Both resulted in increased γ -globin gene expression at day 10 of erythroid differentiation, and the amount of increased γ -globin expression obtained was proportional to the degree of knockdown of Mi2β ( Figure 3A ). Mi2β knockdown with construct #2 resulted in a ~20-fold increase in γ /γ+β-globin mRNA expression compared to ~9-fold in the case of MBD2 knockdown ( Figures 3B and 3C ). At day 10 of differentiation, the level of γ /γ+β-globin gene expression is <1% in both untreated and scramble shRNA controls (Supplemental Figure S3B ). HPLC assay in a representative experiment showed a HbF level of 13.2% of total hemoglobin when Mi2β was knocked down by ~25-30% (Supplemental Table 2 ).
Because complete absence of Mi2β in the bone marrow of mice results in a block in erythroid differentiation at the pro-erythroblast stage 42 , we sought to determine whether or not a partial knockdown of this protein would interfere with erythroid differentiation. Fluorescenceactivated cell sorting using the transferrin receptor (CD71) and Glycophorin A (CD235a) surface markers showed that after Mi2β knockdown, erythroid differentiation proceeds similarly to scramble shRNA controls, as shown in Figure 3D . Interestingly, as erythroid differentiation proceeds, two distinct populations of cells were observed by flow cytometry of both control and Mi2β-knockdown cell populations. The major population was differentiated down the erythroid pathway and expressed both transferrin receptor and Glycophorin A ( Figure 3D , quadrant 2), while the minor population did not stain for either ( Figure 3D, quadrant 3) . When analyzed by morphology, the minor population was found to consist of normally differentiated myeloid cells ( Figures 3G, 3H, 3I ). The size of this myeloid cell population varied among different patientspecific CD34+ progenitor batches, suggesting that a variable fraction of CD34+ cells in each batch assayed was committed to myeloid differentiation before exposure to erythroid differentiation medium. The percentage of myeloid cells was generally higher in Mi2β knockdown samples but this was highly variable across experiments and there was overlap with controls ( Figure 3D ).
The differentiated Mi2β knockdown erythroid cells in quadrant 2 were found to have ~40% Mi2β knockdown ( Figure 3E ) and a very high γ /γ+β-globin gene expression level (15% - Figure S5 ). MBD2 knockdown did not decrease expression of either KLF1 or BCL11A in human primary erythroid cells ( Figure   5C ). These results suggest that Mi2β acts as a positive regulator of BCL11A and KLF1 in
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From contrast to its negative regulatory role as part of the MBD2/NuRD complex 25 . In order to investigate whether or not Mi2β might directly activate the BCL11A and/or KLF1 genes through interactions at their promoter regions, we carried out chromatin immunoprecipitation (ChIP) assays. As shown in Figure 5E , Mi2β is significantly enriched at the proximal promoter region of both the BCL11A and KLF1 genes in primary erythroid cells. Thus Mi2β appears to interact directly with and lead to increased expression of both the BCL11A and KLF1 genes. Figure 6C to Figure 1B ).
Mi2β affects
DISCUSSION
The developmental switch from the fetal γ -globin chain, to the adult β -globin chain, is regulated by multiple factors including DNA methylation, and transcription factors such as KLF1, BCL11A, GATA-1, TR2/TR4, NF-E2 1, 3, 6 , and the MBD2/NuRD complex 44 .
As one of the major components of the MBD2/NuRD complex, Mi2β plays a critical functional role in this repression 25 . Disruption of the interaction between the MBD2 and p66α
coiled coil domains results in a displacement of both p66α and Mi2β from the NuRD complex and leads to a significant de-repression of the γ -globin gene in CID cells 25 . In this study, we have found a novel role for Mi2β, which appears to be independent of its function in MBD2/NuRD and MBD3/NuRD complexes. We observed that knockdown of Mi2β has a greater effect in de- as an activator of the BCL11A and KLF1 genes in both murine and human hematopoietic cells.
As MBD2 knockdown results in slightly increased levels of BCL11A expression, these results confirm that Mi2β regulates the BCL11A and KLF1/EKLF genes independently of the MBD2/NuRD complex. Mi2β occupies the proximal promoter regions of both BCL11A and KLF1, a result consistent with a direct positive regulatory effect.
The concept of Mi2β as a gene activator is supported by previous reports for both the CD4 gene in T-cells 36 and the adult β -globin gene in mice 45 . We have shown previously that a partial knockdown of MBD3 in CID cells has little effect on the expression of the γ -globin gene 25 . Therefore, it seems unlikely that the role of Mi2β as an activator of the BCL11A and KLF1/EKLF genes is mediated through the GATA-1/FOG-1/NuRD or the MBD3/NuRD complexes.
Interestingly, in addition to a marked increase in γ -globin and ε -globin expression after Mi2β knockdown in CID cells, a small increase in β -globin RNA was observed, but expression of no other tested erythroid-specific genes was increased ( Figures 1E and 2C ). Together these results suggest that the silencing effect of Mi2β on erythroid-specific genes in CID cells may be restricted to the β -globin locus. In contrast to the results in CID cells, we observed a decrease in β -globin gene expression in primary human erythroid cells with ~50% Mi2β knockdown, consistent with the predicted effect of decreased KLF1 expression.
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